JJJames Jamison

James Jamison

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


James Jamison has a total of 104 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Acceptability of three smartphone apps to improve adherence to blood pressure medicines in community pharmacies: a qualitative interview study of patients and pharmacy staff

    by James Jamison, Jonathan Scales, Debi Bhattacharya, Jonathan Mant, Stephen Sutton

    Background Around eight million people in England are treated for high blood pressure; however, many do not take their medications as prescribed, which can lead to serious health complications. Community pharmacists can support patients in taking medication, but they often lack time to do so. Smartphone apps may help patients take medicines in this environment. This study explored the experiences and views of patients and pharmacy staff regarding the use of three apps to manage blood pressure medication as part of a randomized feasibility trial. Methods Semi-structured interviews were conducted with 30 participants (22 people with hypertension and eight pharmacy staff ) across eight community pharmacies in the East of England . The data were analysed thematically using a constant comparative approach. Key themes were identified, with findings reported as verbatim quotes. Results Five key themes were identified: Two were associated with the general characteristics of reminder apps and three were related to increased app functionality. Participants welcomed the apps’ reminder notification, ability to track multiple medications, direct messaging with pharmacies, and scanning function for uploading medication details. Patients also recommended additional features, including inputting blood pressure readings and the ability to save details on unused medicines and GP appointments. However, implementing this technology may depend on the capacity and resources available at the pharmacy site. Conclusions This study adds to the growing body of research on the use of smartphone apps for the self-management of medications. We found that digital apps were acceptable to patients using blood-pressure-lowering medicines and were supported by staff in community pharmacies. Apps with additional functionality that enables prescription reordering and facilitates direct communication with pharmacists have the potential to simplify medication management. However, further research is needed to assess their effectiveness and explore the best practices for use across a wider pharmacy setting.

  • Open Access

    Scalable low-cost interventions to support medication adherence in people prescribed treatment for hypertension in primary care: a research programme

    by Stephen Sutton, Katja Beardsell, Debi Bhattacharya, James Brimicombe, Gianna Cadorna, Raquel Conceição, Anna De Simoni, Helen Eborall, Simon Griffin, Pankaj Gupta, et al.

    Background: About 14.9% of people (9.9 million) registered with primary care practices in England and Wales are prescribed medication for hypertension. However, many do not take their medication as prescribed. To address this problem, we need scalable interventions. Objective: To develop a scalable low-cost intervention to support medication adherence in people prescribed medication for hypertension in primary care, and to obtain precise and robust estimates of the effectiveness and cost-effectiveness of the intervention compared with usual care. Design: Systematic reviews and meta-analyses; qualitative meta-synthesis; interviews and focus groups; expert consultations; pre-testing study; randomised feasibility trial; randomised controlled trial of effectiveness and cost-effectiveness; economic modelling. Setting and participants: Primary care practices in England and Wales. Patients prescribed medication for hypertension with poorly controlled blood pressure. Interventions: Very brief intervention delivered by a practice nurse or healthcare assistant followed by a digital intervention (text messaging programme or smartphone app). Main outcome measures: Acceptability, feasibility, fidelity and cost of the interventions. Systolic blood pressure. Biochemical and self-reported measures of medication adherence. Results: Our systematic reviews showed that both app-based and face-to-face interventions in patients with long-term conditions have a positive effect on medication adherence. The meta-synthesis of published qualitative studies showed that: digital interventions to support medication use were perceived as acceptable and useful; a digital intervention would be more effective if it was personalised and tailored; barriers to using digital interventions included lack of interest, lack of confidence and lack of proficiency and experience in using the technology; digital interventions should be simple, easy to navigate and age-appropriate; patients wanted accurate information on their health condition, potential side effects of medication and health consequences of non-adherence; reminder notifications and a self-monitoring feature were perceived as helpful by some patients; some patients suggested that a digital intervention should enable them to communicate with pharmacies, but practitioners were concerned that this would increase their workload. The interview and focus group study identified several barriers to adherence, including forgetting, unpleasant side effects and reluctance to medicate. A digital intervention to support medication adherence was acceptable to patients if it was user-friendly, the content was tailored to the user, and the privacy of user data was protected. Simple reminder messages for taking medication and reordering prescriptions were considered more useful by patients than those providing information on the benefits of medication or the consequences of non-adherence. Patients preferred to receive feedback on their adherence levels in the form of a simple graph, percentage score or statistic. Practitioners thought that it would be feasible to introduce a digital intervention to patients in a very brief face-to-face consultation. In the pre-testing study, participants reported that the interventions we developed were easy to use and that they would recommend them to others. The feasibility trial showed that the combined intervention was acceptable and that a large cost-effectiveness trial was feasible. The main trial showed no difference between arms in systolic blood pressure or medication adherence at 12-month follow-up. The estimate (95% confidence interval) for the difference in means between arms in self-measured systolic blood pressure at 12 months was −0.61 mmHg (−3.05 to 1.82), p = 0.62 [for intervention vs. control (reference group)]. In the base case analysis, the intervention had a mean incremental cost-effectiveness ratio below the usual willingness-to-pay thresholds in the National Health Service in the United Kingdom. The probability of cost-effectiveness was between 77% and 80% at willingness-to-pay thresholds of £15,000, £20,000 and £30,000 per quality-adjusted life-year, but the confidence intervals are wide and cross zero, indicating some chance that the intervention could be less effective and more costly. Limitations: The effectiveness trial was conducted during the COVID-19 pandemic. To reduce the risk of infection, the very brief intervention was delivered by telephone instead of face-to-face, and all study measurements were conducted remotely. This may have led to lower response rates and data quality and lower effectiveness of the intervention. A significant proportion (24%) of participants did not have raised blood pressure at baseline, and self-reported medication adherence was high at baseline, which reduced the possible scope for an intervention effect. Conclusions: The findings on effectiveness do not support the commissioning of the intervention in United Kingdom primary care. The cost-effectiveness findings are more equivocal, showing a high probability of being cost-effective at standard United Kingdom willingness-to-pay thresholds, but with some uncertainty. Future work: Future research should address the challenge of identifying and recruiting people who are poorly adherent and have raised blood pressure and test the intervention in this group. Variants such as face-to-face delivery, adding a follow-up consultation or a purely digital version could also be investigated. Study registration: This study is registered as CRD42017080150; CRD42020164049; ISRCTN12805654; ISRCTN74504989; ISRCTN82013652. Funding: This award was funded by the National Institute for Health and Care Research (NIHR) Programme Grants for Applied Research Programme (NIHR award ref: RP-PG-0615-20013) and is published in full in Programme Grants for Applied Research ; Vol. 14, No. 18. See the NIHR Funding and Awards website for further award information.

  • Open Access

    Randomised controlled trial of a very brief nurse-delivered intervention followed by a digital intervention to support medication adherence and reduce blood pressure in people prescribed treatment for hypertension in primary care: protocol for the Programme on Adherence to Medication (PAM) trial

    by Stephen Sutton, James Jamison, Katja Beardsell, Micah Fineberg, Raquel Conceição, Venus Mirzaei, Catalina Trama Alvarez, Sonia Shpendi, James Brimicombe, Debi Bhattacharya, et al.

    Introduction Hypertension is a global health challenge accounting for 8.5 million deaths worldwide despite the availability of low-cost pharmaceutical treatment. About 14.9% of people (9.9 million) registered with primary care practices in England and Wales are prescribed medication for hypertension. However, many patients with hypertension and associated conditions do not take their medications as prescribed. Non-adherence to antihypertensive medication is associated with increased risk of suboptimal blood pressure (BP) control, complications and all-cause mortality, and increased healthcare costs. The Programme on Adherence to Medication (PAM) trial will estimate the effectiveness and cost-effectiveness of a medication adherence intervention in patients prescribed medication for hypertension with poorly controlled blood pressure in primary care. Methods A two-arm multicentre individually randomised controlled parallel group superiority trial recruiting patients prescribed medication for hypertension with poorly controlled BP in primary care practices in England and Wales. The target sample size is 542. Participants in the Intervention group will receive a very brief intervention delivered remotely (by telephone or video call) by a practice nurse or healthcare assistant followed by a digital intervention (text messaging or smartphone app) in addition to usual care; control group participants will receive usual care alone. The primary outcome is systolic BP measured at 12 months. Medication adherence will be measured by chemical adherence testing of urine samples and self-report. An economic evaluation and a process evaluation will be undertaken. Ethics and dissemination The Cambridge East Independent Research Ethics Committee (REC reference 19/EE/0354), the Health Research Authority (HRA) and Health and Care Research Wales (HCRW) approved the trial. The findings will be disseminated to the scientific community, participating practitioners and patients, relevant patient groups and the public using a range of methods, including journal articles, conference presentations, newsletters and the Programme website. Trial registration number The UK’s Clinical Trial Registry ISRCTN82013652

  • Open Access

    Usability of the Coach-Supported Dementia Prevention App ENHANCE (TailorEd iNtervention for brain HeAlth aNd Cognitive Enrichment) in Older Adults: One-Week Mixed Methods Study (Preprint)

    by Tsz Kiu Clare Yu, Gill Livingston, Richard Boczko, Kealan Forristal, James Jamison, Carl Leckstein, Vrushti Mehta, Hee Kyung Park, Aneesha Singh, Andrew Sommerlad, et al.

    Background: Multidomain dementia-prevention interventions delivered via apps have the potential to reach large populations. However, existing trials have tended to recruit more socioeconomically advantaged participants, raising concerns that the resulting interventions may be less usable for older adults from minority ethnic, lower educational, or lower socioeconomic backgrounds, who are at higher risk of dementia. The Tailored Intervention for Brain Health and Cognitive Enrichment (ENHANCE) app was designed to address this by prioritizing accessibility and engagement across diverse user groups. Objective: This study evaluated the usability and user experience of the ENHANCE prototype during a 1-week at-home supported-use test and explored factors influencing use and engagement among older adults. Methods: We purposively recruited adults aged 60‐80 years without dementia for a 1-week mixed methods usability evaluation through community settings, including groups underrepresented in dementia-prevention trials. Participants had at least 1 of 10 prespecified dementia risk factors, attended a face-to-face onboarding session with a coach, used the app at home for 7 days with ongoing coach support, and completed a posttest interview and satisfaction survey. We analyzed quantitative data, including app usage metrics and survey responses descriptively, and used reflexive thematic analysis of qualitative data from onboarding sessions, posttest interviews, coaching calls, and in-app messages. Results: Ten participants participated in the study. The mean age was 68 (SD 6) years, and 7 were females. Participants represented a wide range of deprivation (Index of Multiple Deprivation deciles: mean 4, SD 2, range 1‐8), with 6 from ethnic minority backgrounds. All met prespecified minimum-use targets (watching a module video, completing a check-in, and playing assigned games at least once). Many demonstrated additional voluntary engagement: 5 rewatched the risk factor video, 7 used the in-app messaging feature, and among the 5 participants with the hypertension module, blood pressure was logged on an average of 5 out of 7 days. Survey responses indicated high satisfaction, perceived usefulness, and ease of use; 9 participants intended to continue using the app and would recommend it to peers. Qualitative analysis identified engagement facilitators, including rewarding game design, familiar interfaces, appropriately challenging gameplay, consistent virtual rewards, trusted expert information combined with peer stories, and coach support. Barriers included unclear visual cues, insufficient accommodation of motor or sensory impairments, and visual discomfort in some games. Conclusions: Older adults found the ENHANCE prototype usable, acceptable, and engaging over 1 week. Human coaching, inclusive design, and integration of expert and peer narratives were highlighted as key engagement drivers. These findings support further feasibility testing to examine longer-term engagement and provide design insights for more inclusive digital health interventions.

  • Open Access

    A blended app and coach support programme to improve brain health

    by James Jamison, Sergi Costafreda-Gonzalez, Gill Livingston

  • Open Access

    Impact of research activity on performance of general practices: a qualitative study.

    by Cassandra Kenning, Juliet A Usher-Smith, James Jamison, Jennifer Jones, Annette Boaz, Paul Little, Christian Mallen, Peter Bower, Sophie Park

    Background There is evidence that engaging in research is directly associated with better performance. If this relationship is to be strengthened, it is necessary to understand the mechanisms which might underlie that relationship.Aim To explore the perspectives of staff and wider stakeholders about mechanisms by which research activity might impact on the performance of general practices.Design & Setting Qualitative study using semi-structured interviews with general practice professionals and wider stakeholders in England.Method Individual interviews with 41 purposively sampled staff in ‘research ready’ or ‘research active’ general practices and with 21 other stakeholders. Interviews were independently coded by three researchers using a Framework approach.Results Participants described potential ‘direct’ and ‘indirect’ impacts on their work. ‘Direct’ impacts included research changing practice work (e.g. additional records searches for particular conditions), bringing in additional resources (e.g. access to investigations or staff) and improving relationships with patients. ‘Indirect’ impacts included job satisfaction (e.g. perception of practice as a centre of excellence and innovation, and the variety afforded by research activity reducing burnout) and staff recruitment (increasing the attractiveness of the practice as a place to work). Respondents identified few negative impacts.Conclusions Staff and stakeholders identified a range of potential impacts of research activity on practice performance, with impacts on their working lives most salient. Negative impacts were not generally raised. Nevertheless, respondents generally discussed potential impacts rather than providing specific examples of those impacts. This may reflect the type of research activity conducted in general practice, often led by external collaborators.

  • Open Access

    Online stroke forum as source of data for qualitative research: insights from a comparison with patients’ interviews

    by James Jamison, Stephen Sutton, Jonathan Mant, Anna De Simoni

    Objective To determine the appropriateness of an online forum compared with face-to-face interviews as a source of data for qualitative research on adherence to secondary prevention medications after stroke. Design A comparison of attributes of two data sources, interviews and a forum, using realistic evaluation; a comparison of themes around adherence according to the Perceptions and Practicalities Approach (PAPA) framework. Setting Interviews were conducted in UK GP practices in 2013 and 2014; online posts were written by UK stroke survivors and family members taking part in the online forum of the Stroke Association between 2004 and 2011. Participants 42 interview participants: 28 stroke survivors (age range 61–92 years) and 14 caregivers (85% spouses). 84 online forum participants: 49 stroke survivors (age range 32–72 years) and 33 caregivers (60% sons/daughters). Results 10 attributes were identified within the two data sources and categorised under three domains (context, mechanisms and outcomes). Participants’ characteristics of forum users were often missing. Most forum participants had experienced a stroke within the previous 12 months, while interviewees had done so 1–5 years previously. All interview themes could be matched with corresponding themes from the forum. The forum yielded three additional themes: influence of bad press on taking statins, criticisms of clinicians’ prescribing practices and caregiver burden in assisting with medications and being advocates for survivors with healthcare professionals. Conclusions An online forum is an appropriate source of data for qualitative research on patients’ and caregivers’ issues with adherence to secondary prevention stroke medications and may offer additional insights compared with interviews, which can be attributed to differences in the approach to data collection.


  • Open Access

    Evaluating practical support stroke survivors get with medicines and unmet needs in primary care: a survey

    by James Jamison, Luis Ayerbe, Gian Luca Di Tanna, Stephen Sutton, Jonathan Mant, Anna De Simoni

    Objectives To design a questionnaire and use it to explore unmet needs with practical aspects of medicine taking after stroke, predictors of medicine taking and to estimate the proportion of survivors who get support with daily medication taking. Design Four workshops with stroke survivors and caregivers to design the questionnaire. A cross-sectional postal questionnaire in primary care. Setting 18 general practitioner practices in the East of England and London. Questionnaires posted between September 2016 and February 2017. Participants 1687 stroke survivors living in the community outside institutional long-term care. Primary outcome measures The proportion of community stroke survivors receiving support from caregivers for practical aspects of medicine taking; the proportion with unmet needs in this respect; the predictors of experiencing unmet needs and missing taking medications. Results A five-item questionnaire was developed to cover the different aspects of medicine taking. 596/1687 (35%) questionnaires were returned. 56% reported getting help in at least one aspect of taking medication and 11% needing more help. 35% reported missing taking their medicines. Unmet needs were associated with receiving help with medications (OR 5.9, PConclusions More than half of patients who replied needed help with taking medication, and 1 in 10 had unmet needs in this regard. Stroke survivors dependent on others have more unmet needs, are more likely to miss medicines and might benefit from focused clinical and research attention. Novel primary care interventions focusing on the practicalities of taking medicines are warranted.


  • Open Access

    Barriers and facilitators to adherence to secondary stroke prevention medications after stroke: analysis of survivors and caregivers views from an online stroke forum

    by James Jamison, Stephen Sutton, Jonathan Mant, Anna De Simoni

    Objective To identify barriers and facilitators of medication adherence in patients with stroke along with their caregivers. Design Qualitative thematic analysis of posts about secondary prevention medications, informed by Perceptions and Practicalities Approach. Setting Posts written by the UK stroke survivors and their family members taking part in the online forum of the Stroke Association, between 2004 and 2011. Participants 84 participants: 49 stroke survivors, 33 caregivers, 2 not stated, identified using the keywords ‘taking medication’, ‘pills’, ‘size’, ‘side-effects’, ‘routine’, ‘blister’ as well as secondary prevention medication terms. Results Perceptions reducing the motivation to adhere included dealing with medication side effects, questioning doctors’ prescribing practices and negative publicity about medications, especially in regard to statins. Caregivers faced difficulties with ensuring medications were taken while respecting the patient’s decisions not to take tablets. They struggled in their role as advocates of patient’s needs with healthcare professionals. Not experiencing side effects, attributing importance to medications, positive personal experiences of taking tablets and obtaining modification of treatment to manage side effects were facilitators of adherence. Key practical barriers included difficulties with swallowing tablets, dealing with the burden of treatment and drug cost. Using medication storage devices, following routines and getting help with medications from caregivers were important facilitators of adherence. Conclusions An online stroke forum is a novel and valuable resource to investigate use of secondary prevention medications. Analysis of this forum highlighted significant barriers and facilitators of medication adherence faced by stroke survivors and their caregivers. Addressing perceptual and practical barriers highlighted here can inform the development of future interventions aimed at improving adherence to secondary prevention medication after stroke.